---
title: "ADXN: Net loss widened to CHF 1.7 million in Q1 2026; urgent funding needed beyond July 2026"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/290779494.md"
description: "Net loss increased to CHF 1.7 million in Q1 2026, with no revenue recognized and cash reserves projected to last through July 2026. The company faces substantial going concern risks and will require additional funding to advance its pipeline and maintain operations.Original document: Addex Therapeutics Ltd [ADXN] Interim report — Jun. 25 2026DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source."
datetime: "2026-06-25T05:27:14.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/290779494.md)
  - [en](https://longbridge.com/en/news/290779494.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/290779494.md)
generator: "portal-rs"
---

# ADXN: Net loss widened to CHF 1.7 million in Q1 2026; urgent funding needed beyond July 2026

Net loss increased to CHF 1.7 million in Q1 2026, with no revenue recognized and cash reserves projected to last through July 2026. The company faces substantial going concern risks and will require additional funding to advance its pipeline and maintain operations.

Original document: Addex Therapeutics Ltd \[ADXN\] Interim report — Jun. 25 2026

**Disclaimer**

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

### Related Stocks

- [ADXN.US](https://longbridge.com/en/quote/ADXN.US.md)

## Related News & Research

- [INVEST: Revenue and profit dropped sharply in H1 2026, with 2026 outlook remaining subdued](https://longbridge.com/en/news/296439091.md)
- [Public Storage announces R$ 0.41 per unit dividend for Q3 2026](https://longbridge.com/en/news/296635332.md)
- [Corning sets Q3 2026 dividend at R$ 0.25 per unit](https://longbridge.com/en/news/296635714.md)
- [Baker Hughes declares Q3 2026 dividend of R$ 0.81 per unit](https://longbridge.com/en/news/296392545.md)
- [EGTX: Q2 2026 revenue up 23% YoY; U.S. Emcitate launch expected Q4 2026 pending FDA approval](https://longbridge.com/en/news/296636890.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**